NEW YORK, Aug. 3 – Cellomics has sold its ArrayScan HCS system for imaging cells to Boehringer Ingelheim Pharmaceuticals, Cellomics said on Friday.

The giant German pharma company will use the system to automate its drug-discovery process, the company said in a statement.

Financial details were not disclosed.